2 ms·
Doing some intersting work though https://x.com/ydeigin/status/1821713858106368484 https://x.com/ydeigin/status/1821713858106368484
by tim333 2y ago
Doing some intersting work though https://x.com/ydeigin/status/1821713858106368484 https://x.com/ydeigin/status/1821713858106368484
- xk_id 2y agoAbsolutely not. He is piggy-backing on the landmark work by other groups; he just re-applied it to the eye organ. The doxycyclin-based approach which this kind of studies are using can't be translated for clinical application in humans and in general partial reprogramming carries the risk of teratomas. So contrary to that tweet, it won't be ready for the clinic for years, decades, maybe never.